Matt Tate

Matt has been with the business since 2006. Initially working on the development of their screening assays and earning a PhD in genetic toxicology, Matt transitioned to the commercial side of the business, working globally with clients to implement the most appropriate testing strategies for their needs. He now leads the business, developing their overall strategy and delivering their plan to build an expert predictive toxicology CRO, whilst remaining passionate about toxicology and engaging with their clients to meet their challenges.